Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10499177rdf:typepubmed:Citationlld:pubmed
pubmed-article:10499177lifeskim:mentionsumls-concept:C0338474lld:lifeskim
pubmed-article:10499177lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:10499177lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:10499177lifeskim:mentionsumls-concept:C0439662lld:lifeskim
pubmed-article:10499177lifeskim:mentionsumls-concept:C0127400lld:lifeskim
pubmed-article:10499177pubmed:issue3lld:pubmed
pubmed-article:10499177pubmed:dateCreated1999-11-24lld:pubmed
pubmed-article:10499177pubmed:abstractTextMultiple sclerosis is generally regarded to be a primarily T-cell driven disease. Recent evidence has refocused interest on antibodies. Adhesion molecules, matrix metalloproteinases, chemokines and cytokines, and nitric oxide and oxygen metabolites all participate in the amplification and effector stages of the disease.lld:pubmed
pubmed-article:10499177pubmed:languageenglld:pubmed
pubmed-article:10499177pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10499177pubmed:citationSubsetIMlld:pubmed
pubmed-article:10499177pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10499177pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10499177pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10499177pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10499177pubmed:statusMEDLINElld:pubmed
pubmed-article:10499177pubmed:monthJunlld:pubmed
pubmed-article:10499177pubmed:issn1350-7540lld:pubmed
pubmed-article:10499177pubmed:authorpubmed-author:MartinoGGlld:pubmed
pubmed-article:10499177pubmed:authorpubmed-author:HartungH PHPlld:pubmed
pubmed-article:10499177pubmed:authorpubmed-author:ArchelosJ JJJlld:pubmed
pubmed-article:10499177pubmed:authorpubmed-author:KieseierB CBClld:pubmed
pubmed-article:10499177pubmed:authorpubmed-author:StorchM KMKlld:pubmed
pubmed-article:10499177pubmed:issnTypePrintlld:pubmed
pubmed-article:10499177pubmed:volume12lld:pubmed
pubmed-article:10499177pubmed:ownerNLMlld:pubmed
pubmed-article:10499177pubmed:authorsCompleteYlld:pubmed
pubmed-article:10499177pubmed:pagination323-36lld:pubmed
pubmed-article:10499177pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10499177pubmed:meshHeadingpubmed-meshheading:10499177...lld:pubmed
pubmed-article:10499177pubmed:meshHeadingpubmed-meshheading:10499177...lld:pubmed
pubmed-article:10499177pubmed:meshHeadingpubmed-meshheading:10499177...lld:pubmed
pubmed-article:10499177pubmed:meshHeadingpubmed-meshheading:10499177...lld:pubmed
pubmed-article:10499177pubmed:meshHeadingpubmed-meshheading:10499177...lld:pubmed
pubmed-article:10499177pubmed:meshHeadingpubmed-meshheading:10499177...lld:pubmed
pubmed-article:10499177pubmed:meshHeadingpubmed-meshheading:10499177...lld:pubmed
pubmed-article:10499177pubmed:year1999lld:pubmed
pubmed-article:10499177pubmed:articleTitleEffector pathways in immune mediated central nervous system demyelination.lld:pubmed
pubmed-article:10499177pubmed:affiliationDepartment of Neurology, Karl-Franzens Universität Graz, Austria. bc.kieseier@kfunigraz.ac.atlld:pubmed
pubmed-article:10499177pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10499177pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10499177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10499177lld:pubmed